Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Clinicaloptions-Her2'
Clinicaloptions-Her2 published presentations and documents on DocSlides.
Denise A. Yardley, MD Sarah Cannon Research Institute
by lily
Senior Investigator, . Breast Cancer Research. Ten...
Her2 + Breast Cancer Laura
by ximena
Bidstrup. Mrs B is a 49 . yo. woman who attended ...
HER2 and Ki67Assessment of regional lymph nodesPhysical examination
by arya
Luminal B-like (HER2-positive):!ER-positive!HER2-p...
HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ
by carny
Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...
Module 9: HER2-Positive and
by norah
Triple-Negative Breast Cancer. Jamie Carroll, APRN...
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
by marina-yarberry
Management of HER2 Over-Expressed Breast Cancer i...
Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer
by danika-pritchard
ASCO-CAP Recommendations For HER2 Testing in Brea...
HER2 TESTING IN BREAST CANCER
by danika-pritchard
Clinical Practice Guideline Update. American Soci...
Metastatic HER2-Positive Breast Cancer: Treatment Selection
by test
First . Line and Beyond. Moderator:. Joseph Gligo...
HER2 TESTING IN BREAST CANCER
by danika-pritchard
Clinical Practice Guideline Update. American Soci...
Advances in the Diagnosis and Treatment of IBS-D:
by felicity
An Update for the Primary Care Setting. This activ...
Advances in Systemic Amyloidosis:
by morton
A Spotlight on New Disease-Modifying . Therapies A...
Metastatic triple-positive
by marcos147
breast. . cancer. . needs. . different. . ther...
Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín
by delcy
Trastuzumab-emtansine. : A . very. . nice. . poi...
Module 9: HER2-Positive and Triple-Negative BC
by unita
Percent with Patients. Number of Patients (Median)...
2020 Year in Review: Breast Cancer
by caroline
Lisa A. Carey MD, . ScM. University of North Carol...
Changes in Breast Cancer Reports After Second Opinion
by unita
Dr. Vicente Marco. Department of Pathology. Hospit...
CA BREAST D r S ana
by oconnor
ishtiaq. . FCPS R3 general surgery unit one UKSO...
Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use
by gelbero
Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...
Antibody–Drug Conjugates
by wang
in Development for . Breast Cancer. Sara A. Hurvit...
Antibody–Drug Conjugates in Development for Non-
by elizabeth
s. mall Cell . Lung Cancer. , Gastric Cancer, and ...
Central Asian Journal of
by cady
15 Medical and Pharmaceutical Sciences Innovation ...
ORIGINALARTICLEBREASTONCOLOGY
by emery
SentinelLymphNodeBiopsyAfterNeoadjuvantChemotherap...
Nanotek & Expo 2014
by DaintyLittlePrincess
Biodegradable . nanobrushes. for drug delivery. ...
Snyder D, Heidel RE, Panella T, Bell J, Orucevic
by Kingslayer
A. University of Tennessee Medical Center – Knox...
6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im
by katrgolden
Contents PageIntended Use 4Summary and Explanation...
Product Pipeline Neratinib
by coursion
across the breast cancer therapy spectrum. Phase I...
Endocrine resistance: molecular pathways and rational development of targeted therapies
by spottletoefacebook
Grazia Arpino. Università di Napoli Federico II. ...
Updates in the Treatment of Breast cancer
by alexa-scheidler
Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...
Metastatic Breast Cancer: A Medical Update
by liane-varnes
Jennifer M. Matro, MD. Rena Rowan Breast Center. ...
Tumor Marker Phenotype Concordance in Second Primary Breast Cancer
by debby-jeon
Monica Brown, MPH, PhD. . California Cancer Regi...
ID DB06366 CATEGORY
by luanne-stotts
Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...
William J.
by tawny-fly
Gradishar. . MD, FACP. Betsy . Bramsen. Profess...
What’s new in Anatomic Pathology Quality Assurance?
by alida-meadow
. Raouf E. Nakhleh, MD. Mayo Clinic Florida. Dis...
Updates on Individual and Universal HIV Treatment Strategies
by norah
EECA INTERACT, November 19, 2019. Stefan Baral, MD...
New and Investigational ART Drugs and Strategies
by elina
Judith S. Currier, MD, . MSc. Division of Infectio...
Targeting KRAS G12C in Solid Tumors
by morton
: . A . New Anticancer Approach . Marwan Fakih, ...
Evolving Options for HBV Therapy:
by desiron
Navigating the New Treatment Landscape. Outline. I...
Use of HCV DAAs with HIV Regimens
by robaut
Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....
Slides for today’s webinar are available on the CIHS website at:
by tatiana-dople
Slides for today’s webinar are available on the...
Load More...
